ACGLO vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ACGLO's Piotroski F-Score of 4/9 indicates a borderline stable financial health, falling short of strong resilience. The absence of an Altman Z-Score raises concern about default risk, though the low Debt/Equity (0.12) and strong profitability margins suggest solid balance sheet fundamentals. The stock trades at a deeply undervalued P/E of 4.31 and Price/Book of 0.31, well below sector averages, with a Graham Number of $83.06 and intrinsic value of $138.38, implying significant upside potential. However, the bearish insider sentiment, lack of analyst coverage, and recent price decline undermine near-term momentum despite strong earnings growth.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
ACGLO vs BRK-B: Head-to-Head Comparison
This page compares Arch Capital Group Ltd. (ACGLO) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.